NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $289,000 | +2.1% | 16,100 | -2.4% | 0.00% | 0.0% |
| Q2 2021 | $283,000 | +11.4% | 16,500 | +29.9% | 0.00% | +50.0% |
| Q1 2021 | $254,000 | +24.5% | 12,700 | +5.8% | 0.00% | 0.0% |
| Q4 2020 | $204,000 | -14.6% | 12,000 | -16.7% | 0.00% | -33.3% |
| Q3 2020 | $239,000 | -52.0% | 14,400 | -33.0% | 0.00% | -50.0% |
| Q2 2020 | $498,000 | +35.0% | 21,500 | +3.9% | 0.01% | +20.0% |
| Q1 2020 | $369,000 | -49.5% | 20,700 | -38.8% | 0.01% | -37.5% |
| Q4 2019 | $730,000 | -1.1% | 33,800 | +179.3% | 0.01% | -11.1% |
| Q3 2018 | $738,000 | +24.9% | 12,100 | 0.0% | 0.01% | +28.6% |
| Q2 2018 | $591,000 | +122.2% | 12,100 | +384.0% | 0.01% | +133.3% |
| Q1 2018 | $266,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |